We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Czech Healthcare Reforms Likely to Impact Pharmaceutical Industry
Czech Healthcare Reforms Likely to Impact Pharmaceutical Industry
February 16, 2011
Healthcare reforms proposed by Czech Republic Health Minister Leos Heger are expected to lead to drug price cuts and new restrictions on the pharmaceutical industry, according to analysts.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor